Journal Club E09: When Provoked Is Not Simple: The HI-PRO Trial

from AZense Journal Club · host Azense Medical Education

HI-PRO: Extended Low-Dose Apixaban Cuts Recurrent VTE by 87% in Provoked Patients with Ongoing Risk

Episode metadata supplied by the publisher feed · Published Jun 2, 2025

Embed this episode

Attribution link and audio player

Ready to play

Journal Club E09: When Provoked Is Not Simple: The HI-PRO Trial

0:00 6:28

1×

No transcript for this episode yet

We transcribe on demand. Request one and we'll notify you when it's ready — usually under 10 minutes.

Similar Episodes

No similar episodes found.

No similar podcasts found.

This episode is 6 minutes long.

This episode was published on June 2, 2025.

Yes. Use the download control on the episode player to save the publisher-provided media file.

URL copied to clipboard!